Free Trial

TG Therapeutics (TGTX) SEC Filings & 10K Form

TG Therapeutics logo
$31.70 -1.66 (-4.98%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$31.53 -0.17 (-0.54%)
As of 01/31/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent TG Therapeutics SEC Filings

DateFilerForm TypeView
01/30/2025
4:15 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:17 PM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:02 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
10:29 AM
TG Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/07/2025
5:01 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:52 PM
Power Sean A (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:45 PM
Darwin Global Management, Ltd. (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
11/12/2024
4:01 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
4:02 PM
Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
11:49 AM
Charney Laurence N (Reporting)
TG Therapeutics (Subject)
Form 144/A
11/12/2024
10:36 AM
Charney Laurence N (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:12 AM
Lonial Sagar (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
12:42 PM
Echelard Yann (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
6:19 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:08 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:04 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:05 PM
Echelard Yann (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:05 PM
Hoberman Kenneth (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:07 PM
HUME DANIEL (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:07 PM
Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:06 PM
Lonial Sagar (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
2:53 PM
Lonial Sagar (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:48 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
2:08 PM
Lonial Sagar (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
10:23 AM
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM (Filed by)
TG Therapeutics (Subject)
Form PX14A6G
05/01/2024
6:05 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:34 PM
TG Therapeutics (Filer)
Form DEFA14A
04/18/2024
3:56 PM
TG Therapeutics (Filer)
Form PRE 14A
03/15/2024
3:37 PM
Lonial Sagar (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:52 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:10 PM
Lonial Sagar (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
10:24 AM
Charney Laurence N (Reporting)
TG Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:23 PM
TG Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2024
6:24 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:53 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2024
2:30 PM
Darwin Global Management, Ltd. (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TGTX) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners